Nijkamp Maarten W, van der Bilt Jarmila D W, de Bruijn Menno T, Molenaar I Quintus, Voest Emile E, van Diest Paul J, Kranenburg Onno, Borel Rinkes Inne H M
Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Ann Surg. 2009 May;249(5):814-23. doi: 10.1097/SLA.0b013e3181a38ef5.
The aim of this study was to assess how thermal ablation of colorectal liver metastases affects the outgrowth of micrometastases in the transition zone (TZ) between ablated tissue and the unaffected reference zone (RZ) in 2 different murine models.
Thermal destruction therapies of nonresectable colorectal liver metastases, including radiofrequency ablation (RFA), can provide tumor clearance, but local recurrences are common.
Three days after intrasplenic injection of C26 colon carcinoma cells, RFA was applied to the left liver lobe. Perinecrotic microcirculation, tissue hypoxia, hypoxia inducible factor (HIF)-1alpha and HIF-2alpha, and the outgrowth of micrometastases both in the TZ and in the RZ were evaluated over time.
In 2 different animal models, the outgrowth of micrometastases in the TZ following RFA was stimulated approximately 4-fold compared to tumor growth in the RZ. Accelerated tumor growth in the TZ was associated with microcirculatory disturbances, prolonged hypoxia, and stabilization of HIF-1alpha and HIF-2alpha in the tumor cells. In addition, RFA induced the formation of new hepatic vessels that sprouted from existing sinusoids and grew into the generated necrotic lesion. Surprisingly, the accelerated tumor growth was not associated with these vessels. Treatment with 17DMAG prevented HIF-1alpha and HIF-2alpha stabilization and selectively reduced tumor growth in the TZ by approximately 40% without affecting tumor growth in sham-operated mice or in the RZ of RFA-treated mice. PTK787/ZK-222584, a nonselective Vascular Endothelial Growth Factor (VEGF)-receptor inhibitor, reduced RFA-stimulated tumor growth and tumor growth in the RZ to a similar extent.
We conclude that RFA stimulates the outgrowth of tumor cells at the lesion periphery. Angiogenesis is not the driving force behind RFA-stimulated tumor growth, but other hypoxia/HIF-activated pathways are likely to be important.
本研究旨在评估在两种不同的小鼠模型中,结直肠癌肝转移灶的热消融如何影响消融组织与未受影响的参照区(RZ)之间过渡区(TZ)内微转移灶的生长。
包括射频消融(RFA)在内的不可切除结直肠癌肝转移灶的热破坏疗法可实现肿瘤清除,但局部复发很常见。
在脾内注射C26结肠癌细胞三天后,对左肝叶进行RFA治疗。随时间评估坏死周围的微循环、组织缺氧、缺氧诱导因子(HIF)-1α和HIF-2α,以及TZ和RZ内微转移灶的生长情况。
在两种不同的动物模型中,与RZ中的肿瘤生长相比,RFA后TZ内微转移灶的生长被刺激了约4倍。TZ中肿瘤生长加速与微循环紊乱、缺氧时间延长以及肿瘤细胞中HIF-1α和HIF-2α的稳定有关。此外,RFA诱导了从现有肝血窦中长出并长入产生的坏死病变中的新肝血管形成。令人惊讶的是,肿瘤生长加速与这些血管无关。用17DMAG治疗可防止HIF-1α和HIF-2α稳定,并选择性地将TZ中的肿瘤生长降低约40%,而不影响假手术小鼠或RFA治疗小鼠的RZ中的肿瘤生长。PTK787/ZK-222584,一种非选择性血管内皮生长因子(VEGF)受体抑制剂,在相似程度上降低了RFA刺激的肿瘤生长以及RZ中的肿瘤生长。
我们得出结论,RFA刺激了病变周边肿瘤细胞的生长。血管生成不是RFA刺激肿瘤生长的驱动力,但其他缺氧/HIF激活途径可能很重要。